Latest Dopamine antagonists Stories
LOS ALTOS, Calif., Jan.
LOS ALTOS, Calif., Feb.
WASHINGTON, June 20, 2011 /PRNewswire/ -- The U.S. Supreme Court is expected to rule shortly on whether generic drug companies must adequately warn doctors about new or revised risks to patients who have taken the drugs they make. (Pliva v Mensing No.
Reglan, metoclopramide never approved for use in infants HOUSTON, May 3 /PRNewswire-USNewswire/ -- Recently, researchers have observed a disturbing trend in neonatal units across the country: doctors prescribing Reglan -- also known by its generic name, metoclopramide -- to treat premature infants.
WILMINGTON, N.C., Sept. 9 /PRNewswire/ -- Wilmington Pharmaceuticals announced today the U.S.
Researchers in Israel have shown that the anti-nausea drug metoclopramide does no obvious harm to the fetus in pregnant women.
Nausea and vomiting are telltale indicators of pregnancy, affecting more than 80 percent of future mothers. For a few moms-to-be, symptoms can become so severe that hospitalization is required.
SAN DIEGO, May 5 /PRNewswire/ -- - Evoke Pharma, Inc., a privately-held specialty pharmaceutical company, announced today that it has initiated a Phase 2b clinical trial to evaluate EVK-001 for the treatment of adults with symptoms of diabetic gastroparesis.
The US Food and Drug Administration is requiring makers of the heartburn drug Reglan to add a â€œblack boxâ€ warning to inform patients that long term or high doses of the drug have been linked to involuntary movement throughout the body.